thenewsfacts.com
  • Home
  • Latest News
  • Trending News
  • Technology
  • entertainment
  • Sports
  • Business
thenewsfacts.comthenewsfacts.com
Font ResizerAa
Search
  • Home
  • Latest News
  • Trending News
  • Technology
  • entertainment
  • Sports
  • Business
Follow US
© thenewsfacts : All Rights Reserved.

Home » COVID Vaccine for 15-18 Years: Over 50% Children Gets COVAXIN

COVID Vaccines

COVID Vaccine for 15-18 Years: Over 50% Children Gets COVAXIN

TheNewsFacts
Last updated: January 19, 2022 12:36 pm
TheNewsFacts
Share
COVID Vaccine for 15-18 Years: Over 50% Children Gets COVAXIN
SHARE

COVID Vaccine for 15-18 Years has got tremendous momentum in India since its launch. India’s Health Minister Mansukh Mandaviya shared an update on Tuesday evening to announce that more than fifty per cent of India’s population in the 15 to 18 years age group have received their first dose of the Covid-19 vaccine.

Health Minister wrote that it was a big day in India’s fight against Covid-19 and congratulated the country’s youngsters. Mansukh Mandaviya went on to say that his “young friends’ enthusiasm for vaccination” was inspiring the rest of India.

“Big day for India’s fight against Covid-19! Over 50% of our youngesters between 15-18 age group have received their 1st dose of Covid-19 vaccine. Well done, my young friends! Your enthusiasm for vaccination is inspiring people all over India,” Mansukh Mandaviya tweeted.

Big day for India's fight against COVID-19!

Over 50% of our youngesters between 15-18 age group have received their 1st dose of #COVID19 vaccine.

Well done, my Young Friends!

Your enthusiasm for vaccination is inspiring people all over India 🇮🇳#SabkoVaccineMuftVaccine pic.twitter.com/BVFsIzJPYm

— Dr Mansukh Mandaviya (@mansukhmandviya) January 18, 2022

As Covid-19 cases began to surge in India, the nation initiated a vaccination drive for teenagers in the age group of 15-18 years on January 3. An announcement to this end was made by Prime Minister Narendra Modi in the last week of December. So far, only Bharat Biotech’s Covaxin vaccine is being administered to those below the age of 18 years.

On Monday, Dr NK Arora told India Today that India will begin vaccinating 12-14-year-olds by March of this year. Dr Arora is chairman of the central government’s Covid-19 Working Group of the National Technical Advisory Group on Immunisation (NTAGI).

TAGGED:BHARAT BIOTECH NEWSCOVAXIN FOR CHILDRENCovaxin NewsCovid vaccineCOVID VACCINE FOR CHILDRENcovid vaccines
Share This Article
Email Copy Link Print
Previous Article COVID Vaccine Precautionary Dose: India Crosses 50 Lakh Milestone COVID Vaccine Precautionary Dose: India Crosses 50 Lakh Milestone
Next Article Moon Knight: Oscar Isaac is Marvel’s New Superhero Moon Knight: Oscar Isaac is Marvel’s New Superhero

Your Trusted Source for Accurate and Timely Updates!

We're committed to providing accurate and unbiased news as it unfolds, earning the trust of a large audience. Stay informed with our news updates on the latest events and trends, keeping you ahead of the curve.
FacebookLike
XFollow
InstagramFollow

Popular Posts

Double Crown for King Kohli, ODI Player & Team of the Year 2023

June 3, 2024: King Kohli's remarkable 2023 continues to be celebrated as the Indian batting…

By
TheNewsFacts

Rs.100Cr defamation lawsuit filed against defaming blogger by ITC

A defaming blog by SEBI Registered investment advisory firm MRG Capital senior executive about ITC…

By
TheNewsFacts

Kerala Tops as India’s highest COVID-19 contributor now

Today covid-19 cases data in India revealed 42,766 new coronavirus cases and 1,206 deaths in…

By
TheNewsFacts

You Might Also Like

India increases surveillance as more coronavirus news breaks in China
COVID-19

India increases surveillance as more coronavirus news breaks in China

By
TheNewsFacts
Bharat Biotech Nasal Vaccine as Covid booster dose, first in Hospitals: Govt
COVID Vaccines

Bharat Biotech Nasal Vaccine as Covid Booster Dose, First in Hospitals: Govt

By
TheNewsFacts
COVAXIN effective even against High Risk Delta Variants - Ne AIIMS Study
COVID Vaccines

COVAXIN effective even against High Risk Delta Variants – AIIMS New Study

By
TheNewsFacts
Japan Approves COVAXIN booster dose for Travelers; reinforces the effectiveness of Universal Covid Vaccine
COVID Vaccines

Japan Approves COVAXIN booster dose for Travelers; reinforces the effectiveness of Universal Covid Vaccine

By
TheNewsFacts
thenewsfacts thenewsfacts

About US


TheNewsFacts: Brings you the interesting facts, news facts and updates from India an the world across politics, tech, entertainment, business, tending, and more. We deliver what you love to read.
Top Categories
  • Latest News
  • Trending News
  • Paris Olympics 2024
  • Sports
  • Entertainment
  • Business
  • Technology
Usefull Links
  • About The News Facts
  • Latest News
  • Privacy Policy
  • Editorial Policy
  • Disclaimer
  • Contact Us
Follow us
Facebook Twitter Instagram

© thenewsfacts. All Rights Reserved.

Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?